This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $16,320.00, is a firm fixed-price delivery order for the procurement of XPCOV2/FLU/RSV-10 diagnostic testing products, including GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract supports the detection of infectious diseases such as COVID-19, influenza, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed price of $6,800.00 and a completion date of March 17, 2025. The contract is for the provision of XPCOV2/FLU/RSV-10 testing products, which are molecular diagnostic kits and systems used to detect COVID-19, influenza, and respiratory syncytial virus. Cepheid is an established federal contractor,...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
The U.S. Defense Logistics Agency (DLA) awarded a $10,880.00 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a completion date of February 13, 2025, is for the provision of XPCOV2/FLU/RSV-10 molecular diagnostic products and services, including GeneXpert diagnostic systems, reagents, test kits, and maintenance. This award is part of a larger Indefinite Delivery Contract vehicle with the Department of Veterans...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The $3,400.00 firm fixed-price delivery order is for the provision of XPCOV2/FLU/RSV-10 test kits and associated diagnostic equipment and services, with a final completion date of January 21, 2025. Cepheid is the prime contractor on this contract, which has no set-aside designation. The award is part of Cepheid's larger federal contract portfolio, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
This federal contract award, valued at $4,080.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order for XPCOV2/FLU/RSV-10 testing products, which include diagnostic tests for COVID-19, influenza, and respiratory syncytial virus. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2024. This award does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $4,620.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid, the prime contractor, will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory...